Saireito (114) Increases IC50 and Changes T-Cell Phenotype When Used in Combination with Prednisolone Therapy in Human Peripheral Blood Mononuclear Cells

Prednisolone (PSL), a type of corticosteroid used to treat autoimmune diseases, can increase the risk of infection and osteoporosis. Saireito (114), a Kampo medicine, has an immunosuppressive effect; with its use, the dose of steroids can be reduced. However, its mechanism when used with PSL is stil...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Kyosuke, Kiyomi, Anna, Imai, Shinobu, Sugiura, Munetoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901328/
https://www.ncbi.nlm.nih.gov/pubmed/35265152
http://dx.doi.org/10.1155/2022/9738989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8901328/
https://www.ncbi.nlm.nih.gov/pubmed/35265152
http://dx.doi.org/10.1155/2022/9738989

Ejemplares similares